If you are unable to see the message below, view the web version.

OPEN
D'Amato

OPEN Pre–Conference: October 3, 2012
Oncology Pharmacy 2012:
New Treatments and Trends


Now Available for ACPE and ANCC Credit!

The business of running an oncology pharmacy is complex and ever-changing. Are you up to date on new treatments and trends?

Dear INSERT_CUSTOM03 INSERT_LAST_NAME,

The Association of Community Cancer Centers' Oncology Pharmacy Education Network's Pre-conference on October 3, 2012, in San Antonio, provides the strategies and information that you need to keep pace and stay competitive. The one-day meeting, "Oncology Pharmacy 2012: New Treatments and Trends," explores pharmacy practice in both the hospital and private practice settings.

This pre-conference to the ACCC 29th National Oncology Conference stands out for its exceptional value and broad range of sessions that will help you and your pharmacy team:

  1. Gain a better understanding of new indications and new oncology drugs, as well as promising oncology drugs that are on the horizon for 2013.
  2. Compare and contrast the pros and cons of whether insurers should cover gene-targeted cancer therapies for off-label uses.
  3. Identify major issues surrounding the dispensing of oral anti-cancer therapies, from the role of specialty pharmacy to patient counseling to "meaningful use" and electronic health record technology.
  4. Learn how hospital pharmacies will be affected by the Affordable Care Act extension of the 340B Drug Discount Program.
  5. Find out how hospital/practice mergers and consolidations may affect finances and operations of your oncology pharmacy as well as patient safety.

Registration is just $169. If you pay for and attend the full ACCC 29th National Oncology Conference, registration is free.

Register Today!

Take advantage of ACCC's discounted registration fees.

Sincerely,

Steve D'Amato, RPh, BCOP
Chair, OPEN


ACPE

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of the program includes attending the accredited session(s) and completing a Record of Attendance/Evaluation Form. CPE credit will be issued by The University of Texas at Austin College of Pharmacy Continuing Education Office via CPE Monitor approximately 4-6 weeks following the program. This Knowledge-based activity has been accredited for 0.55 CEUs or 5.5 contact hours.

This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.

University of Kentucky

The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is offered for a maximum of ANCC 6.0 contact hours.

Learning Objectives:
Upon participating in the October 2012 Oncology Pharmacy Education Network Conference:

  • Attendees will be able to discuss all new indications and new oncology drugs, as well as promising oncology drugs that are on the horizon for 2013.
  • Attendees will be able to compare and contrast the pros and cons of whether insurers should cover gene-targeted cancer therapies for off-label uses.
  • Attendees will be able to identify and list major issues surrounding the dispensing of oral anti-cancer therapies, from the role of specialty pharmacy to patient counseling to “meaningful use” and electronic health record technology.
  • Attendees will be able to describe major challenges for hospital pharmacies with the Affordable Care Act extension of the 340B Drug Discount Program.
  • Attendees will be able to define how hospital/practice mergers and consolidations may affect finances and operations of the oncology pharmacy as well as patient safety.

Target Audience: This pre-conference is designed for oncology pharmacists, pharmacy directors, financial officers, and administrators who contribute to decisions about which drugs should be used for cancer patients.


© Copyright 2012 Association of Community Cancer Centers. All Rights Reserved
Email: info@accc-cancer.org
Voice: 301.984.9496
Web: www.accc-cancer.org

footer